A
Abraham Nudelman
Researcher at Bar-Ilan University
Publications - 191
Citations - 10023
Abraham Nudelman is an academic researcher from Bar-Ilan University. The author has contributed to research in topics: Prodrug & Butyrate. The author has an hindex of 36, co-authored 188 publications receiving 9058 citations. Previous affiliations of Abraham Nudelman include Tel Aviv University.
Papers
More filters
Journal ArticleDOI
NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities.
TL;DR: 1H and 13C chemical shifts of what are, in the authors' experience, the most popular “extra peaks” in a variety of commonly used NMR solvents are collected, in the hope that this will be of assistance to the practicing chemist.
Journal ArticleDOI
NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist
Gregory R. Fulmer,Alexander J. M. Miller,Nathaniel H. Sherden,Hugo E. Gottlieb,Abraham Nudelman,Brian M. Stoltz,John E. Bercaw,Karen I. Goldberg +7 more
TL;DR: Tables of 1H and 13C NMR chemical shifts have been compiled for common organic compounds often used as reagents or found as products or contaminants in deuterated organic solvents as discussed by the authors.
Journal ArticleDOI
Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II–Mediated Form of Cell Death
TL;DR: It is shown that doxorubicin-DNA adducts induce a more cytotoxic response in HL-60 cells than doxorbicin as a single agent, and that theseAdducts are more cytOToxic than topoisomerase II-mediated lesions.
Journal ArticleDOI
The power and potential of doxorubicin-DNA adducts.
TL;DR: The adducts appear to be more cytotoxic than doxorubicin alone, and also less susceptible to drug‐efflux forms of resistance, they offer new approaches to improving the anticancer activity of the anthracyclines.
Journal ArticleDOI
Novel anticancer prodrugs of butyric acid. 2.
Abraham Nudelman,Margaretta Ruse,Adina Aviram,Ester Rabizadeh,Matityahu Shaklai,Yael Zimrah,Ada Rephaeli +6 more
TL;DR: In vivo and in vitro results suggest that (pivaloyloxy)methyl butyrate (1a) is a potential antineoplastic agent.